Patents by Inventor Nufar Edinger

Nufar Edinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHIMERIC PROTEINS FOR TARGETING dsRNA
    Publication number: 20220213158
    Abstract: Described herein are recombinant chimeric proteins comprising a double stranded RNA (dsRNA) binding domain and a cancer-cell targeting domain for targeting of dsRNA to cancer cells. Methods of use of the described chimeric proteins are also provided herein.
    Type: Application
    Filed: January 24, 2022
    Publication date: July 7, 2022
    Inventors: Alexander LEVITZKI, Yael Langut, Nufar Edinger
  • Chimeric proteins for targeting dsRNA
    Patent number: 11230580
    Abstract: Described herein are recombinant chimeric proteins comprising a double stranded RNA (dsRNA) binding domain and a cancer-cell targeting domain for targeting of dsRNA to cancer cells. Methods of use of the described chimeric proteins are also provided herein.
    Type: Grant
    Filed: March 8, 2018
    Date of Patent: January 25, 2022
    Assignee: TARGIMMUNE THERAPEUTICS AG
    Inventors: Alexander Levitzki, Yael Langut, Nufar Edinger
  • CHIMERIC PROTEINS FOR TARGETING dsRNA
    Publication number: 20180346596
    Abstract: Described herein are recombinant chimeric proteins comprising a double stranded RNA (dsRNA) binding domain and a cancer-cell targeting domain for targeting of dsRNA to cancer cells. Methods of use of the described chimeric proteins are also provided herein.
    Type: Application
    Filed: March 8, 2018
    Publication date: December 6, 2018
    Inventors: Alexander LEVITZKI, Yael Langut, Nufar Edinger